Geode Capital Management
PLRX icon

Geode Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Geode Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Buy
578,577
+161,303
+39% +$196K ﹤0.01% 3496
2026
Q1 		$526K Sell
417,274
-175,422
-30% -$221K ﹤0.01% 3565
2025
Q4 		$723K Buy
592,696
+5,287
+0.9% +$7.94K ﹤0.01% 3466
2025
Q3 		$870K Buy
587,409
+4,823
+0.8% +$7.36K ﹤0.01% 3430
2025
Q2 		$676K Sell
582,586
-770,457
-57% -$1.09M ﹤0.01% 3461
2025
Q1 		$1.83M Buy
1,353,043
+36,395
+3% +$221K ﹤0.01% 3072
2024
Q4 		$17.3M Sell
1,316,648
-1,660
-0.1% -$22.7K ﹤0.01% 2041
2024
Q3 		$14.8M Buy
1,318,308
+31,221
+2% +$391K ﹤0.01% 2147
2024
Q2 		$13.8M Buy
1,287,087
+72,204
+6% +$931K ﹤0.01% 2130
2024
Q1 		$18.1M Buy
1,214,883
+27,685
+2% +$457K ﹤0.01% 1982
2023
Q4 		$21.5M Buy
1,187,198
+60,984
+5% +$927K ﹤0.01% 1867
2023
Q3 		$19.5M Buy
1,126,214
+137,742
+14% +$2.39M ﹤0.01% 1839
2023
Q2 		$17.9M Buy
988,472
+558,253
+130% +$13.2M ﹤0.01% 1923
2023
Q1 		$11.4M Buy
430,219
+80,611
+23% +$2.3M ﹤0.01% 2170
2022
Q4 		$6.76M Buy
349,608
+21,740
+7% +$454K ﹤0.01% 2496
2022
Q3 		$6.85M Buy
327,868
+106,885
+48% +$2.05M ﹤0.01% 2490
2022
Q2 		$1.77M Sell
220,983
-184,832
-46% -$1.18M ﹤0.01% 3156
2022
Q1 		$2.84M Buy
405,815
+6,121
+2% +$62.5K ﹤0.01% 3073
2021
Q4 		$5.39M Buy
399,694
+79,240
+25% +$1.26M ﹤0.01% 2856
2021
Q3 		$5.41M Buy
320,454
+38,598
+14% +$819K ﹤0.01% 2867
2021
Q2 		$8.21M Sell
281,856
-276
-0.1% -$8.59K ﹤0.01% 2601
2021
Q1 		$11.1M Buy
282,132
+133,331
+90% +$4.33M ﹤0.01% 2289
2020
Q4 		$3.38M Buy
148,801
+13,729
+10% +$344K ﹤0.01% 2804
2020
Q3 		$3.06M Buy
135,072
+116,579
+630% +$2.91M ﹤0.01% 2655
2020
Q2 		$600K Buy
+18,493
New +$491K ﹤0.01% 3306

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Geode Capital Management's PLRX Position: Q2 2026 in Review

Geode Capital Management increased its Pliant Therapeutics (PLRX) stake by 39% in Q2 2026, buying an estimated $196K and bringing the position to 578,577 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #3496.

Geode Capital Management first reported a position in PLRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $21.5M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Geode Capital Management held 578,577 shares of Pliant Therapeutics worth $660K as of Q2 2026.
  • Geode Capital Management bought 161,303 Pliant Therapeutics shares in Q2 2026, an estimated $196K.
  • Pliant Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3496 holding.
  • Geode Capital Management first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Geode Capital Management's Pliant Therapeutics position peaked at $21.5M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.